Free Trial
NASDAQ:ASPI

ASP Isotopes Q2 2026 Earnings Results & Report

ASP Isotopes logo
$1.70 -0.17 (-8.82%)
As of 01:22 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ASP Isotopes missed analyst earnings expectations but beat on revenue in its Q2 2026 results, released August 14, 2026. The company reported EPS of -$0.28 versus the -$0.17 consensus estimate, while revenue of $5.12 million topped the $4.47 million estimate by $657 thousand.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens
Conference Call
7:00 AM ET

ASP Isotopes EPS Results

Actual EPS
-$0.28
Consensus EPS
-$0.17
Beat/Miss
Missed by -$0.11
One Year Ago EPS
N/A
EPS Beat Rate
1 of last 5 quarters

ASP Isotopes Revenue Results

Actual Revenue
$5.12 million
Expected Revenue
$4.47 million
Beat/Miss
Beat by +$657.00 thousand
YoY Revenue Growth
N/A

Earnings Documents

ASP Isotopes Q2 2026 Earnings FAQ

ASP Isotopes (NASDAQ:ASPI) reported earnings of -$0.28 per share for Q2 2026, missing the consensus estimate of -$0.17. The report was announced on Friday, August 14, 2026.

ASP Isotopes reported revenue of $5.12 million for Q2 2026, against a consensus estimate of $4.47 million.

ASP Isotopes Earnings Headlines

Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
See More ASP Isotopes Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ASP Isotopes? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ASP Isotopes and other key companies, straight to your email.

About ASP Isotopes

ASP Isotopes (NASDAQ:ASPI) is an advanced materials company focused on producing and commercializing enriched isotopes. Its proprietary Aerodynamic Separation Process is designed to separate isotopes and support production across a range of applications.

The company’s targeted products include isotopes used in medical imaging and pharmaceuticals, semiconductor manufacturing, quantum technologies and nuclear energy. Examples include molybdenum-100, silicon-28 and ytterbium-176.

ASP Isotopes is headquartered in the United States and has pursued isotope-enrichment operations in South Africa. Its work centers on developing production capabilities and supplying specialized isotopes to customers in industrial and scientific markets.

View ASP Isotopes Profile